← Back to Clinical Trials
Recruiting NCT07413887

NCT07413887 The STIME Project: Intersectoral Prevention of Severe Youth Mental Health Difficulties

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07413887
Status Recruiting
Phase —
Sponsor Center for Clinical Research and Prevention
Condition Preventive Intervention
Study Type INTERVENTIONAL
Enrollment 1,200 participants
Start Date 2025-11-20
Primary Completion 2028-02-01

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
'Signs of Disordered Eating''Signs of Self-Harm''Signs of Internalizing'

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,200 participants in total. It began in 2025-11-20 with a primary completion date of 2028-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of participation in five different STIME (Strengthened Cross-Sectoral Initiative for Children and Young People's Mental Health) interventions: 'Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Self-Harm', 'Take the Control Back', and 'The Parent Pilots'. The hypothesis is that participation in one of these interventions will be more effective than Management As Usual (MAU). Each intervention consists of three core components: early identification and screening, therapy based on evidence-informed manuals, and support within the child's learning environment.

Eligibility Criteria

Each of the interventions has elaborate and narrowly defined inclusion and exclusion criteria. These are listed below for each intervention. 'Signs of Internalizing' Inclusion criteria * Adolescents aged 12-17 years * Mild to moderate impairment in daily functioning (e.g., reduced engagement in school, social life, or leisure activities compared to before symptoms) * Adolescents with well-managed ADHD or autism may be included if they demonstrate sufficient mentalizing abilities and can benefit from the intervention with parental support * Presence of both anxiety and depressive symptoms, neither of which dominates or meets full diagnostic criteria * The family is motivated to participate Exclusion criteria * Symptoms of moderate to severe depression * Presence of OCD, PTSD, agoraphobia, panic disorder, or other psychiatric conditions * Low cognitive functioning * Moderate to severe functional impairment (e.g., school dropout, extreme social withdrawal, daily reliance on adult support, lack of motivation for treatment) * Recent unsuccessful psychological treatment * Primary problems related to family dynamics or a highly burdened family situation * Increased or acute suicide risk * Presence of self-harm or symptoms of disordered eating 'Signs of Disordered Eating' Inclusion criteria * Children and adolescents aged 10-17 years * High body dissatisfaction, preoccupation with food and/or body image, and/or early behavioral signs of an eating disorder * Stable physical condition, manageable in consultation with the adolescent's general practitioner * Able to consume food with guidance and support * The family is motivated to participate Exclusion criteria * Previous treatment for an eating disorder * Symptoms meeting criteria for specialized psychiatric treatment * Low cognitive functioning * Significant weight loss * Solely restrictive or selective eating without other eating disorder symptoms * Severe comorbidity * Increased or acute suicide risk * Eating difficulties solely related to lifestyle factors 'Signs of Self-Harm' Inclusion criteria * Adolescents aged 12-17 years * Current thoughts of self-harm * At least one episode of direct (non-suicidal) self-harm within the past three months * The family is motivated to participate Exclusion criteria * Increased suicide risk * Psychiatric disorder requiring further assessment or not adequately treated * Low cognitive functioning * Self-harm only in socially accepted contexts (e.g., piercings or tattoos) * Only indirect self-harm (e.g., excessive substance use) * Only self-harm by proxy (involving another person) 'Take the Control Back' Inclusion criteria * Children and adolescents aged 5-17 years * Experiencing obsessive thoughts and/or compulsive behaviors of mild to moderate severity * Experiencing self-perceived distress related to obsessive thoughts and/or compulsive behaviors * Experiencing obsessive thoughts as egodystonic, and thus aware that they are excessive (for the youngest participants, this criterion may be waived in cases of limited insight) * Functioning is impaired by obsessive thoughts and/or behaviors, e.g., reduced school functioning, social difficulties, or impaired functioning at home * The family is motivated to participate Exclusion criteria * Symptoms meeting criteria for specialized psychiatric treatment * Has another psychiatric disorder that requires assessment or is not adequately managed * Has difficulties other than obsessive thoughts and behaviors that currently constitute the primary burden, and which must be addressed first * Has previously received OCD treatment within psychiatric care (may be offered STIME if assessed but not treated due to mild severity) * Has an increased or acute risk of suicide * Has low functioning for other reasons, e.g., significantly reduced cognitive functioning 'the Parent Pilots' Inclusion criteria * Parents of children aged 3-10 years who experience developmentally inappropriate difficulties with restlessness, hyperactivity, attention, and/or impulsivity * The symptoms must be present at home as a minimum, but may also occur across settings such as home, daycare, and school * The child's difficulties must be significant enough to affect overall daily functioning * The parents are motivated to participate Exclusion Criteria: * Symptoms of attention difficulties that require psychiatric treatment * Presence of another psychiatric disorder that requires treatment * Previous treatment for ADHD within the psychiatric system * Low level of functioning due to other causes, such as significantly reduced cognitive functioning

Contact & Investigator

Central Contact

Michaela Louise Schiøtz, PhD, cand.scient.san.publ.

✉ michaela.louise.schioetz@regionh.dk

📞 +4527333083

Frequently Asked Questions

Who can join the NCT07413887 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 17 Years, studying Preventive Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07413887 currently recruiting?

Yes, NCT07413887 is actively recruiting participants. Contact the research team at michaela.louise.schioetz@regionh.dk for enrollment information.

Where is the NCT07413887 trial being conducted?

This trial is being conducted at Frederiksberg, Denmark.

Who is sponsoring the NCT07413887 clinical trial?

NCT07413887 is sponsored by Center for Clinical Research and Prevention. The trial plans to enroll 1,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology